Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 7,702 shares at $18.78 ($145K) on 2023-02-24, disclosed to the SEC on 2023-02-27.
Open-market sale of $145k ACAD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.78 | 3,851 | $72K | 50.0% |
| 2 | $18.78 | 3,851 | $72K | 50.0% |
| Total | $18.78 avg | 7,702 | $145K | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |